Advances in Immunotherapy of KRAS-mutated Non-small Cell Lung Cancer

Advances in Immunotherapy of KRAS-mutated Non-small Cell Lung Cancer

In epidemiological statistics, the incidence rate and mortality rate of malignant lung tumors rank among the top. Non-small cell lung cancer (NSCLC) constitutes an important part of lung cancer and has become a key focus of clinical research and treatment. Among the genomic characteristics of NSCLC,...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyue YANG, Zhiwei TANG, Li MA, Ran CHEN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2025-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
kras mutation
immunotherapy
immune checkpoint inhibitors
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2025.101.08
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items